Search for: "Freedom Pharmaceuticals, Inc" Results 41 - 60 of 112
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Nov 2010, 7:24 am by Anna Christensen
, Inc.Amicus brief for Teva Pharmaceuticals, et al.Amicus brief for Securities Industry and Financial Markets Association, et al.Amicus brief for IntelAmicus brief for Facebook Inc., et al.Amicus brief for Electronic Frontier Foundation, et al.Amicus brief for CTIA - The Wireless AssociationAmicus brief for Apple Inc.Amicus brief for Acushnet, et al.Amicus brief for Thirty-Six ProfessorsPetitioner's reply The following two cases were consolidated by the Court: Title: Arizona Free… [read post]
3 May 2016, 1:42 am by Dennis Crouch
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
8 Sep 2014, 4:55 am
This one is Chanel Inc. v Chanel’s Salon and Chanel Jones, 2:14-cv-00304, and sees fashion and cosmetics company Chanel as plaintiff. [read post]
13 Aug 2019, 6:03 am
PepsiCo, Inc. regarding whether use of another’s trademark in a marketing slogan is fair use. [read post]
12 Apr 2020, 6:03 am by Kluwer Patent blogger
” Israel invoked an emergency patent-suspension clause, allowing it to import a generic version of anti-viral drug Kaletra produced by AbbVie Inc. [read post]
17 May 2015, 4:00 am by Administrator
Pharmaceuticals: Amending PleadingsSanofi-Aventis v. [read post]
25 Feb 2011, 1:26 pm by Christa Culver
Chamber of CommerceAmicus brief of Pharmaceutical Research and Manufacturers of AmericaPetitioner's reply Title: Wine Country Gift v. [read post]
3 Mar 2013, 8:42 pm by Madhulika Vishwanathan
 Subsequently, I wrote about the draft policy proposal issued by Department of Pharmaceuticals (DOP) on price negotiation of patented drugs. [read post]
28 Nov 2019, 10:39 am
| IPEC no longer London-focuses as IP small claims track reaches courts in Newcastle, Manchester, Cardiff and beyond | Can an employee’s freedom of expression trump their confidentiality obligations? [read post]
15 Oct 2007, 1:04 am
ALM Privacy Policy / Contact Us © 2007 ALM Properties, Inc. [read post]
7 Dec 2014, 3:29 pm
‘It’s Idenix Pharmaceutical, Inc v Gilead Sciences, Inc & Others [2014] EWHC 3916 (Pat) (01 December 2014)’, Darren might answer. [read post]
3 Jan 2018, 5:10 am
On the heels of the Ericsson decision, further briefing on the waiver issue was recently authorized in Mylan Pharmaceuticals Inc., et al. v. [read post]
8 Mar 2011, 7:21 am by Nabiha Syed
The Court also declined to review S&M Brands, Inc. v. [read post]
14 Mar 2011, 8:12 pm by Christa Culver
Teleflex Inc., the Federal Circuit has erred in applying a “lead compound test” as the exclusive standard for determining whether a patent claim directed to a new chemical compound is “obvious” and therefore invalid under 35 U.S.C. § 103(a).Certiorari stage documents:Opinion below (Federal Circuit)Petition for certiorariBrief in oppositionPetitioners' replyAmicus brief of Generic Pharmaceutical Association Title: Kiyemba v. [read post]